Table 5.

Baseline predictive factors for visual and anatomical outcomes at 12 months.

Parameter		Final BCVA		Final CMT
		Median (IQR), logMAR	Univariate analysis ( P- value)	Median (IQR), $\mu$ m	Univariate analysis ( P- value)
Gender	Female	0.4 (0.2–07)	0.596	316.0 (268.0–372.0)	0.172
	Male	0.4 (0.2–0.7)	327.5 (280.2–439.2)
Disease duration	$<$ 3 months	0.4 (0.2–0.8)	0.058	334.0 (269.0–414.0)	0.984
	$>$ 3 months	0.5 (0.2–0.9)	328.0 (278.2–419.2)
	Unknown	0.3 (0.1–0.5)	316.5 (282.0–432.2)
BRVO location	TS	0.3 (0.2–0.7)	0.038	337.5 (282.0–434.8)	0.480
	TI	0.5 (0.2–0.8)	323.5 (257.8–369.2)
	SHR	0.6 (0.3–1.7)	310.5 (264.5–360.0)
	IHR	0.8 (0.6–1.8)	262.5 (208.2–499.8)
	Macular	0.3 (0.2–0.5)	316 (273.0–420.0)
Hypertension	Yes	0.4 (0.2—-0.7)	0.522	325.0 (281.0–416.0)	0.708
	No	0.4 (0.2—-0.8)	327.0 (264.0–412.2)
Dyslipidemia	Yes	0.3 (0.2–0.7)	0.465	325.0 (280.0–444.0)	0.484
	No	0.4 (0.2–0.7)	324.5 (268.8–400.5)
Diabetes mellitus	Yes	0.4 (0.3–0.7)	0.418	302.0 (271.0–449.0)	0.665
	No	0.3 (0.2–0.7)	329.0 (279.0–410.5)
Blood dyscrasia	Yes	0.7 (0.2–0.7)	0.555	387.0 (233–387.0)	0.612
	No	0.4 (0.2–0.7)	324.0 (278.0–414.0)
Glaucoma	Yes	0.5 (0.4–0.7)	0.257	320.5 (252.5–429.8)	0.605
	No	0.3 (0.2–0.7)	326.0 (280.0–407.00)
Phakic status	Phakic	0.4 (0.2–0.7)	0.348	325.0 (280.0–414.0)	0.638
	Pseudophakic	0.4 (0.3–0.7)	328.0 (256.2–415.5)
Subretinal fluid	Yes	0.5 (0.2–0.8)	0.086	321.0 (266.0–416.0)	0.490
	No	0.3 (0.2–0.6)	328.5 (282.5–414.0)
DRIL	Yes	0.5 (0.2–0.8)	$<$ 0.01	336.0 (279.2–436.8)	0.070
	No	0.3 (0.1–0.4)	308.0 (272.0–361.0)
HF	Yes	0.4 (0.2–0.7)	0.401	310.0 (267.0–407.0)	0.101
	No	0.4 (0.2–0.9)	336.0 (292.0–421.5)
ERM	Yes	0.4 (0.2–0.9)	0.667	363.0 (325.8–426.2)	0.060
	No	0.4 (0.2–0.7)	320.0 (273.0–410.5)
RPE disruption ${ }^a$	Yes	1.2 (0.6–1.9)	0.007	333.5 (230.8–345.5)	0.678
	No	0.4 (0.2–0.7)	323.0 (278.0–416.0)
EZ disruption ${ }^a$	Yes	0.7 (0.4–1.0)	$<$ 0.01	338.0 (275.2–452.0)	0.393
	No	0.2 (0.1–0.4)	316.0 (278.0–381.0)
ELM disruption ${ }^a$	Yes	0.7 (0.4–1.0)	$<$ 0.01	336.0 (269.0–438.5)	0.873
	No	0.3 (0.2–0.5)	321.5 (278.8–392.0)
${ }^a$ At the level of the fovea BCVA, best corrected visual acuity; BRVO, branch retinal vein occlusion; CMT, central macular thickness; DRIL, disorganization of the inner retinal layers; ELM, external limiting membrane; ERM, epiretinal membrane; EZ, ellipsoid zone; HF, hyperreflective foci; IHR, inferior hemiretinal; IQR, interquartile range; RPE, retinal pigment epithelium; SHR, superior hemiretinal; TI, temporal inferior; TS, temporal superior logMAR, logarithm minimum angle of resolution